PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930089
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930089
The global ventilators market plays a critical role in modern healthcare by supporting patients who are unable to breathe independently due to severe respiratory conditions. According to Fortune Business Insights, the ventilators market size was valued at USD 8.21 billion in 2025 and is projected to grow to USD 8.65 billion in 2026. Over the long term, the market is forecasted to reach USD 13.73 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 5.94% during the 2026-2034 forecast period.
North America dominated the global ventilators market in 2025 with a 59.38% market share, supported by high ICU admission rates, advanced healthcare infrastructure, and strong adoption of critical care technologies.
Market Overview
Ventilators are life-support devices that provide mechanical ventilation to patients who cannot breathe adequately on their own. These devices are widely used in intensive care units (ICUs), emergency departments, and increasingly in homecare settings. Ventilation can be broadly categorized into invasive and non-invasive modes, with invasive ventilation being preferred in severe and emergency conditions due to its clinically proven effectiveness.
The rising prevalence of chronic respiratory diseases, growing geriatric population, and increasing number of ICU admissions worldwide are major factors driving demand for ventilators. According to the Society of Critical Care Medicine, more than 5 million patients are admitted to ICUs annually in the U.S., with approximately 40-50% requiring mechanical ventilation, highlighting the essential role of these devices.
Impact of COVID-19 on the Ventilators Market
The COVID-19 pandemic significantly accelerated demand for ventilators globally. The sudden surge in critically ill patients exposed gaps in healthcare infrastructure and ventilator availability across multiple countries. According to the World Health Organization, around 4.7 million COVID-19 cases were reported globally as of May 18, 2020, many of which required ICU admission and respiratory support.
In the U.S., estimates suggested that nearly 960,000 COVID-19 patients could require mechanical ventilation, compared to an available supply of approximately 200,000 ventilators, including full-featured and non-full-featured devices. This supply-demand gap prompted governments and manufacturers to rapidly scale production, further influencing long-term market growth.
Market Trends
Scaling Up Production Capacity
Key manufacturers responded to the pandemic by rapidly increasing production. For instance, Medtronic increased production by 40%, Philips targeted a fourfold capacity increase, and Getinge AB expanded output from 10,000 units in 2019 to 26,000 units in 2020. These initiatives strengthened global supply and supported sustained market expansion.
Technological Advancements
Manufacturers are focusing on advanced ICU ventilators, portable systems, improved connectivity, and enhanced monitoring features. The integration of digital platforms and cloud-based monitoring systems is improving patient management and clinical outcomes, particularly in critical care environments.
Market Drivers
Rising ICU Admissions
The increasing number of ICU admissions due to respiratory diseases, lifestyle factors such as smoking and obesity, and infectious diseases is a major growth driver. In Germany, approximately 42% of ICU patients require mechanical ventilation, while in the U.S., around 45% of ICU admissions need ventilatory support, underscoring strong demand across developed markets.
Product Innovation
Key players continue to launch technologically advanced ventilators. Notable introductions include Drager's Evita V600 and V800 ICU ventilators, Hamilton Medical's HAMILTON-C6, and Nihon Kohden's NKV-550 series, supporting clinical efficiency and expanding adoption.
Market Restraints
Despite strong demand, the market faces challenges from ventilator-associated complications such as ventilator-associated pneumonia (VAP). Studies indicate that around 80% of nosocomial pneumonias are linked to mechanical ventilation, which may limit usage in certain cases and impact clinical decision-making.
By Type
The market is segmented into adult and pediatric & neonatal ventilators. The adult segment dominated with a 61.01% market share in 2026, driven by higher ICU admissions among the elderly population.
By Interface
Based on interface, the market includes invasive and non-invasive ventilators. The invasive segment held a dominant 88.84% share in 2026, due to higher adoption in ICU settings.
By End User
Hospitals represent the largest end-user segment, accounting for 56.29% market share in 2026, supported by rising ICU admissions and expanding hospital infrastructure.
The North America ventilators market was valued at USD 4.87 billion in 2025, with the U.S. market projected to reach USD 4.74 billion by 2026. Europe holds the second-largest share, with Germany projected at USD 0.53 billion and the U.K. at USD 0.10 billion by 2026.
In Asia Pacific, growth is driven by increasing ICU admissions and local manufacturing. By 2026, China is projected to reach USD 0.51 billion, Japan USD 0.32 billion, and India USD 0.29 billion.
Conclusion
The global ventilators market, valued at USD 8.21 billion in 2025, is projected to grow to USD 8.65 billion in 2026 and reach USD 13.73 billion by 2034. Continuous growth in ICU admissions, technological advancements, and rising demand for critical care equipment are expected to support market expansion during the forecast period.
Segmentation By Type
By Interface
By End-User
By Geography